{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:10:04Z","timestamp":1794521404245,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017607","name":"Shenzhen Fundamental Research Program","doi-asserted-by":"crossref","award":["JCYJ20220530144404011"],"award-info":[{"award-number":["JCYJ20220530144404011"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Fundamental Research Program","doi-asserted-by":"crossref","award":["JCYJ20220530144404010"],"award-info":[{"award-number":["JCYJ20220530144404010"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Futian District key specialty funding","award":["QZDZK-202413"],"award-info":[{"award-number":["QZDZK-202413"]}]},{"name":"Futian Healthcare Research Project","award":["FTWS2023037"],"award-info":[{"award-number":["FTWS2023037"]}]},{"name":"Outstanding Medical Innovation Talent Program of The Eighth Affiliated Hospital of Sun Yat-sen University","award":["YXYXCXRC202414"],"award-info":[{"award-number":["YXYXCXRC202414"]}]},{"name":"Guangdong Foundation for Basic and Applied Research Enterprise Joint Fund","award":["2023A1515220186"],"award-info":[{"award-number":["2023A1515220186"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03171-7","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:48:44Z","timestamp":1775447324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The prognostic significance of cholesterol, high-density lipoprotein and glucose (CHG) index in evaluating all-cause mortality risk in metabolic dysfunction-associated steatotic liver disease (MASLD) individuals: evidence from two cohort studies"],"prefix":"10.1186","volume":"25","author":[{"given":"Jicai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjie","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"3171_CR1","doi-asserted-by":"crossref","unstructured":"Balakrishnan S, Ranganathan P, Prabhudesai KS, Vijay R, Gawali VP, Kareenhalli V. MASLD Risk Score (MRS) and Random Forest model (RF Model): Novel tools for screening and severity assessment of MASLD. Comput Biol Med 2025, 192(Pt B):110314.","DOI":"10.1016\/j.compbiomed.2025.110314"},{"key":"3171_CR2","doi-asserted-by":"publisher","first-page":"e041744","DOI":"10.1161\/JAHA.125.041744","volume":"15","author":"Y Wang","year":"2026","unstructured":"Wang Y, Chen K, Wang C, Hu Z, Zhu X, Liu L. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease With Features of Cerebral Small-Vessel Disease on Magnetic Resonance Images: A Large Cross-Sectional Study. J Am Heart Assoc. 2026;15:e041744. https:\/\/doi.org\/10.1161\/JAHA.125.041744.","journal-title":"J Am Heart Assoc"},{"key":"3171_CR3","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1111\/liv.15999","volume":"44","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Xu F, Liu S, Zhu S, Zhang S, Wu J, et al. Long-term risk of cardiovascular disease associated with MASLD and different cardiometabolic risk factors in IBD patients: A prospective cohort study. Liver Int. 2024;44:2315\u201328. https:\/\/doi.org\/10.1111\/liv.15999.","journal-title":"Liver Int"},{"key":"3171_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/dom.70168","volume":"28","author":"Z Zhou","year":"2026","unstructured":"Zhou Z, Gao N, Liu J, Ma X, Ge Z, Ji C. An interpretable machine learning model for predicting metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes. Diabetes Obes Metab. 2026;28:122\u201336. https:\/\/doi.org\/10.1111\/dom.70168.","journal-title":"Diabetes Obes Metab"},{"key":"3171_CR5","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3350\/cmh.2024.0246","volume":"31","author":"Y Wang","year":"2025","unstructured":"Wang Y, Song SJ, Jiang Y, Lai JC, Wong GL, Wong VW, et al. Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31:S51\u20135175. https:\/\/doi.org\/10.3350\/cmh.2024.0246.","journal-title":"Clin Mol Hepatol"},{"key":"3171_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12933-025-03034-7","volume":"25","author":"L Pan","year":"2025","unstructured":"Pan L, Shen M, Liu Y, Huang C, Lin R, Qin G, et al. Proteomic signature of metabolic dysfunction-associated steatotic liver disease and risk of atherosclerotic cardiovascular disease. Cardiovasc Diabetol. 2025;25:20. https:\/\/doi.org\/10.1186\/s12933-025-03034-7.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12933-025-02906-2","volume":"24","author":"Z Guo","year":"2025","unstructured":"Guo Z, Xiong Z, Zhang W, Chen G, Xie M, Zhou Z, et al. Association between cholesterol, high-density lipoprotein, and glucose index and risks of cardiovascular and all-cause mortality in patients with calcific aortic valve stenosis: the ARISTOTLE cohort study. Cardiovasc Diabetol. 2025;24:393. https:\/\/doi.org\/10.1186\/s12933-025-02906-2.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/dom.70338","volume":"28","author":"R Tian","year":"2026","unstructured":"Tian R, Tian X, Chen S, Li X, Zheng M, Wu S, et al. Association of cumulative exposure to cholesterol, high-density lipoprotein, and glucose index with the risk of cardiovascular disease and all-cause mortality: A longitudinal cohort study. Diabetes Obes Metab. 2026;28:1453\u201362. https:\/\/doi.org\/10.1111\/dom.70338.","journal-title":"Diabetes Obes Metab"},{"key":"3171_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-026-03079-2","volume":"25","author":"H Zhu","year":"2026","unstructured":"Zhu H, Liu L, Yang S, Fu Y, Pan Y, Fu Q, et al. Association of cholesterol, high-density lipoprotein and glucose (CHG) index with mortality risk in metabolic dysfunction-associated steatotic liver disease (MASLD) adults: results from two prospective cohorts. Cardiovasc Diabetol. 2026;25:23. https:\/\/doi.org\/10.1186\/s12933-026-03079-2.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-024-02244-9","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Liu L, Qi Y, Han N, Xu H, Wang Z, et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2024;23:156. https:\/\/doi.org\/10.1186\/s12933-024-02244-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000004181","author":"J Bu","year":"2025","unstructured":"Bu J, Mi N, Liang Z, Xie P, Long C, Yang M, et al. The mediating role of inflammation in cancer risk among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study. Int J Surg. 2025. https:\/\/doi.org\/10.1097\/JS9.0000000000004181.","journal-title":"Int J Surg"},{"key":"3171_CR12","doi-asserted-by":"publisher","first-page":"101602","DOI":"10.1016\/j.jhepr.2025.101602","volume":"7","author":"H Zheng","year":"2025","unstructured":"Zheng H, Wu K, Zheng H, Chen G, Lan Y, Chen S, et al. High systemic inflammation response index and increased cardiovascular risk and mortality in MASLD: A prospective cohort study. JHEP Rep. 2025;7:101602. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101602.","journal-title":"JHEP Rep"},{"key":"3171_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23:188. https:\/\/doi.org\/10.1186\/s12933-024-02287-y.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23:8. https:\/\/doi.org\/10.1186\/s12933-023-02115-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24:12. https:\/\/doi.org\/10.1186\/s12933-024-02572-w.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43:61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"key":"3171_CR17","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/jcsm.13001","volume":"13","author":"P Charatcharoenwitthaya","year":"2022","unstructured":"Charatcharoenwitthaya P, Karaketklang K, Aekplakorn W. Muscle strength, but not body mass index, is associated with mortality in patients with non-alcoholic fatty liver disease. J Cachexia Sarcopenia Muscle. 2022;13:2393\u2013404. https:\/\/doi.org\/10.1002\/jcsm.13001.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3171_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12986-017-0206-2","volume":"14","author":"H Dai","year":"2017","unstructured":"Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond). 2017;14:49. https:\/\/doi.org\/10.1186\/s12986-017-0206-2.","journal-title":"Nutr Metab (Lond)"},{"key":"3171_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-025-02675-y","volume":"24","author":"D Mo","year":"2025","unstructured":"Mo D, Zhang P, Zhang M, Dai H, Guan J. Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study. Cardiovasc Diabetol. 2025;24:116. https:\/\/doi.org\/10.1186\/s12933-025-02675-y.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-025-02616-9","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu J, Li T, Qu Y, Wang Y. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes. Cardiovasc Diabetol. 2025;24:52. https:\/\/doi.org\/10.1186\/s12933-025-02616-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12944-025-02714-3","volume":"24","author":"S Wei","year":"2025","unstructured":"Wei S, Yu S, Qian C, Xu Z, Jia Y, Chen B. Exploring the U-shaped nonlinear relationship of CHG index with metabolic syndrome and mortality risks in metabolic syndrome patients. Lipids Health Dis. 2025;24:294. https:\/\/doi.org\/10.1186\/s12944-025-02714-3.","journal-title":"Lipids Health Dis"},{"key":"3171_CR22","doi-asserted-by":"publisher","first-page":"1511319","DOI":"10.3389\/fendo.2025.1511319","volume":"16","author":"B Wan","year":"2025","unstructured":"Wan B, Wang S, Hu S, Han W, Qiu S, Zhu L, et al. The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity. Front Endocrinol (Lausanne). 2025;16:1511319. https:\/\/doi.org\/10.3389\/fendo.2025.1511319.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3171_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12986-024-00804-0","volume":"21","author":"S Yu","year":"2024","unstructured":"Yu S, Li Q, Yang H, Guo X, Li G, Sun Y. Triglyceride-glucose index predicts all-cause mortality, but not cardiovascular mortality, in rural Northeast Chinese patients with metabolic syndrome: a community-based retrospective cohort study. Nutr Metab (Lond). 2024;21:27. https:\/\/doi.org\/10.1186\/s12986-024-00804-0.","journal-title":"Nutr Metab (Lond)"},{"key":"3171_CR24","doi-asserted-by":"publisher","first-page":"1643360","DOI":"10.3389\/fendo.2025.1643360","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H, Tang G, Yuan Y, Gu P, Wang A, Zhao S, et al. Cholesterol, high-density lipoprotein, and glucose index is associated with renal survival in patients with IgA nephropathy. Front Endocrinol (Lausanne). 2025;16:1643360. https:\/\/doi.org\/10.3389\/fendo.2025.1643360.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3171_CR25","doi-asserted-by":"publisher","first-page":"101182","DOI":"10.1016\/j.lanepe.2024.101182","volume":"49","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhong Z, Gue Y, Banach M, McDowell G, Mikhailidis DP, et al. Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015). Lancet Reg Health Eur. 2025;49:101182. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101182.","journal-title":"Lancet Reg Health Eur"},{"key":"3171_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12933-025-02729-1","volume":"24","author":"B Dong","year":"2025","unstructured":"Dong B, Chen Y, Yang X, Chen Z, Zhang H, Gao Y, et al. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0\u20133 and the development of a machine learning prediction model: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:163. https:\/\/doi.org\/10.1186\/s12933-025-02729-1.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR27","doi-asserted-by":"publisher","first-page":"102454","DOI":"10.1016\/j.ando.2025.102454","volume":"86","author":"LH Bu","year":"2025","unstructured":"Bu LH, He LN, Liu X, Wu JX, Yang YQ, Yang YH, et al. Association of triglyceride-glucose index with all-cause and cause-specific mortality in different subgroups: A prospective study in the UK Biobank. Ann Endocrinol (Paris). 2025;86:102454. https:\/\/doi.org\/10.1016\/j.ando.2025.102454.","journal-title":"Ann Endocrinol (Paris)"},{"key":"3171_CR28","doi-asserted-by":"publisher","unstructured":"\u015etefan AG, Clenciu D, Vladu IM, Mitrea A, Protasiewicz-Timofticiuc DC, Ro\u015fu MM, et al. Relationship Between Insulin Resistance Indicators and Type 2 Diabetes Mellitus in Romania. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/ijms26209888.","DOI":"10.3390\/ijms26209888"},{"key":"3171_CR29","doi-asserted-by":"publisher","first-page":"120557","DOI":"10.1016\/j.atherosclerosis.2025.120557","volume":"411","author":"S Wissel","year":"2025","unstructured":"Wissel S, Scharnagl H, Kleber ME, Delgado G, Moissl A, Kr\u00e4mer B, et al. Fatty liver-index, systemic inflammation and cardiovascular mortality. Results from the LURIC study. Atherosclerosis. 2025;411:120557. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120557.","journal-title":"Atherosclerosis"},{"key":"3171_CR30","doi-asserted-by":"publisher","first-page":"1664891","DOI":"10.3389\/fneur.2025.1664891","volume":"16","author":"H Luwen","year":"2025","unstructured":"Luwen H, Linlin L, Ming Y, Lei X. A comparative analysis of the cholesterol-high-density lipoprotein-glucose index and the triglyceride-glucose index in predicting in-hospital mortality in critically ill ischemic stroke patients. Front Neurol. 2025;16:1664891. https:\/\/doi.org\/10.3389\/fneur.2025.1664891.","journal-title":"Front Neurol"},{"key":"3171_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12933-025-02758-w","volume":"24","author":"X Gao","year":"2025","unstructured":"Gao X, Chen T, Zhou F, Sun Y, Zhang J, Li X, et al. The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2025;24:200. https:\/\/doi.org\/10.1186\/s12933-025-02758-w.","journal-title":"Cardiovasc Diabetol"},{"key":"3171_CR32","doi-asserted-by":"publisher","first-page":"103781","DOI":"10.1016\/j.numecd.2024.10.019","volume":"35","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhang W, Liu Z, Ou J, Sun Y, Zhang L, et al. Association between systemic inflammation markers and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease. Nutr Metab Cardiovasc Dis. 2025;35:103781. https:\/\/doi.org\/10.1016\/j.numecd.2024.10.019.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3171_CR33","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.jcte.2025.100427","volume":"43","author":"Q Hang","year":"2026","unstructured":"Hang Q, Xu T, Guo J, Li R, Zhao K, Guo Y, et al. Remnant cholesterol inflammatory index and MASLD in U.S. adults: mediation role of triglyceride-glucose index. J Clin Transl Endocrinol. 2026;43:100427. https:\/\/doi.org\/10.1016\/j.jcte.2025.100427.","journal-title":"J Clin Transl Endocrinol"},{"key":"3171_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12876-025-03888-x","volume":"25","author":"Z Xin","year":"2025","unstructured":"Xin Z, Feng L, Yu Q, Shi Y, Tang T, Tong X, et al. Triglyceride glucose waist circumference and non alcoholic fatty liver disease: a systematic review and meta analysis. BMC Gastroenterol. 2025;25:328. https:\/\/doi.org\/10.1186\/s12876-025-03888-x.","journal-title":"BMC Gastroenterol"},{"key":"3171_CR35","doi-asserted-by":"publisher","first-page":"1555300","DOI":"10.3389\/fendo.2025.1555300","volume":"16","author":"SJ Liu","year":"2025","unstructured":"Liu SJ, Duan JH, Chen YY, Gu SL, He YH, Xue MM, et al. Unraveling the triglyceride-glucose index: a key predictor of liver fat content and the amplifying role of BMI: evidence from a large physical examination data. Front Endocrinol (Lausanne). 2025;16:1555300. https:\/\/doi.org\/10.3389\/fendo.2025.1555300.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3171_CR36","doi-asserted-by":"publisher","first-page":"103797","DOI":"10.1016\/j.numecd.2024.103797","volume":"35","author":"R Dong","year":"2025","unstructured":"Dong R, Tian T, Luo Z, Chang D, Xue H, Qu S, et al. Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease. Nutr Metab Cardiovasc Dis. 2025;35:103797. https:\/\/doi.org\/10.1016\/j.numecd.2024.103797.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3171_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.clnesp.2025.01.041","volume":"66","author":"Y Li","year":"2025","unstructured":"Li Y, Pan T, Wang Y, Wang G, Wang F. The predictive value of triglyceride-glucose-high density lipoprotein-body mass index (TGH-BMI) for different degrees of hepatic steatosis and liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD). Clin Nutr ESPEN. 2025;66:290\u2013301. https:\/\/doi.org\/10.1016\/j.clnesp.2025.01.041.","journal-title":"Clin Nutr ESPEN"},{"key":"3171_CR38","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jhep.2024.10.015","volume":"82","author":"Q Huang","year":"2025","unstructured":"Huang Q, Qadri SF, Bian H, Yi X, Lin C, Yang X, et al. A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease. J Hepatol. 2025;82:781\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2024.10.015.","journal-title":"J Hepatol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03171-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03171-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03171-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:26:16Z","timestamp":1779409576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03171-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03171-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CHARLS study was conducted in line with the principles stated in the Declaration of Helsinki and received approval from the Institutional Review Board of Peking University (IRB00001052-11015). Before their involvement in the CHARLS study, all participants gave their written informed consent. The research design and implementation of NHANES follow the ethical principles outlined in the Helsinki Declaration. This study utilized data from the NHANES project that were publicly available and approved by the National Center for Health Statistics (NCHS) Ethics Review Board (ERB). NHANES requires informed consent from participants and ensures their privacy and information security. All of the data used in this study are deidentified, and most of the data are publicly available. The research adhered to the STROBE guidelines for reporting observational studies in epidemiology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}